Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

DPH outlines harm‑reduction strategy as fentanyl drives recent rise in overdose deaths

San Francisco Health Commission · February 18, 2020
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

DPH presented semiannual overdose data showing fentanyl-driven increases in deaths, described harm‑reduction measures (naloxone distribution, syringe services, fentanyl test strips), and outlined immediate and longer-term actions including a meth sobering center, low‑barrier buprenorphine outreach and a findtreatment.org bed‑availability tool.

DPH staff told the Health Commission that death‑reporting lags (to collect toxicology, scene and medical history) produce roughly a 5–6 month delay before complete overdose mortality data are available, and that the department would move from annual to semiannual public reporting to improve situational awareness. Presenters said fentanyl became prominent in the local drug supply in 2018 and that fentanyl‑involved deaths rose substantially in 2019.

DPH described a continuum…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans